繁体中文
设为首页
加入收藏
当前位置:药品说明书与价格首页 >> 糖尿病 >> 新药动态 >> FDA批准一次性的预充式胰岛素笔,用于控制成人和儿童的血糖

FDA批准一次性的预充式胰岛素笔,用于控制成人和儿童的血糖

2013-01-19 12:09:54  作者:  来源:互联网  浏览次数:279  文字大小:【】【】【
简介:FDA批准一次性的预充式胰岛素笔,用以控制成人及4岁和4岁以上儿童的血糖 美国FDA批准了一种一次性预充式胰岛素笔——Apidra SoloSTAR[格鲁辛胰岛素(rDNA)注射剂]用于改善成人及儿童(≥4岁)1型糖尿病患者或成人 ...

FDA批准一次性的预充式胰岛素笔,用以控制成人及4岁和4岁以上儿童的血糖

美国FDA批准了一种一次性预充式胰岛素笔——Apidra SoloSTAR[格鲁辛胰岛素(rDNA)注射剂]用于改善成人及儿童(≥4岁)1型糖尿病患者或成人2型糖尿病患者的血糖控制情况。
该胰岛素笔的内容物为速效胰岛素类似物Apidra
继2007年来得时[Lantus SoloSTAR,甘精胰岛素(rDNA)注射剂]获得批准和上市后,Apidra SoloSTAR又获得批准。这样,需同时应用来得时和Apidra控制血糖的糖尿病患者,在这两种药物都有了笔式给药装置后,使用起来将更为便利。基础餐时治疗方案(“三短一长”胰岛素治疗方案)结合每天一次的来得时作为基础胰岛素治疗以及餐时Apidra快速治疗,这样就很接近正常的生理性胰岛素分泌模式。
这两种胰岛素笔是由研究者历经4年精心研制而成,被设计成了不同的颜色,以帮助患者区分填充了2种截然不同胰岛素(速效和长效)的笔。
一项特殊的比较性研究揭示了这两种胰岛素笔的区别。建议患者在使用之前,仍应仔细检查笔上的说明,以保证使用的是正确的笔。


Medication name
Generic name:
Insulin Glulisine - Injection
Pronunciation: (IN-sue-lin GLUE-lih-seen)
Brand name(s): Apidra
Uses
Insulin glulisine is a man-made product almost identical to human insulin. It is used to treat diabetes mellitus. Like other insulin products, it works by helping sugar (glucose) get into cells. It starts working faster and lasts for a shorter time than regular insulin.Insulin glulisine is usually used in combination with a medium- or long-acting insulin product to control high blood sugar.Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke.
How to use
Read the Patient Information Leaflet provided by your pharmacist before you start using insulin glulisine and each time you get a refill. If you have any questions regarding the information, consult your doctor or pharmacist.Learn all preparation and usage instructions, including how to inject this medication properly and how to self-manage your diabetes (e.g., monitoring blood glucose, recognizing and treating high/low blood sugar). For additional information, consult your doctor, diabetic educator, or pharmacist.Before using, inspect this product visually for particles or discoloration. If either is present, do not use the insulin.Before injecting each dose, clean the injection site with rubbing alcohol. It is important to change the location of the injection site daily to avoid developing problem areas under the skin (lipodystrophy). Insulin glulisine may be injected in the abdominal wall, the thigh, or the back of the upper arm.Inject this medication under the skin within 15 minutes before eating a meal or within 20 minutes after starting the meal as directed by your doctor. Because this insulin is fast-acting, not eating immediately after giving a dose of this insulin may lead to low blood sugar (hypoglycemia).The dosage is based on your medical condition and response to therapy. Measure each dose very carefully because even small changes in the amount of insulin may have a large effect on your blood sugar levels.Use this medication regularly in order to get the most benefit from it. To help you remember, use it at the same time(s) each day.Do not inject this medication into a muscle. Also, insulin glulisine must not be given into a vein unless you are in the hospital where you can be closely monitored because severely low blood sugar may result.If you are directed to inject this insulin with an infusion pump, read the instruction manual and directions that come with the infusion pump. If you have any questions regarding the information, consult your doctor, diabetic educator, or pharmacist. Avoid exposing the pump or its tubing to direct sunlight or other heat sources.This product may be mixed only with certain other insulin products such as NPH insulin. Consult your pharmacist about which products may be mixed and the proper method for mixing insulin. Never inject a mixture of different insulins into a vein. Do not mix insulins if you are using an insulin pump.Do not change brands or types of insulin without directions on how to do so from your doctor.Learn how to store and discard needles and medical supplies safely. Consult your pharmacist.
Precautions
Before using insulin glulisine, tell your doctor or pharmacist if you are allergic to it; or to other insulins; or if you have any other allergies. This product may contain inactive ingredients (such as cresol), which can cause allergic reactions or other problems. Talk to your pharmacist for more details.Do not use this medication when you have low blood sugar (hypoglycemia).Before using this medication, tell your doctor or pharmacist your medical history, especially of: kidney disease, liver disease, thyroid problems.You may experience blurred vision, dizziness, or drowsiness due to extremely low or high blood sugar levels. Do not drive, use machinery, or do any activity that requires alertness or clear vision until you are sure you can perform such activities safely.Limit alcohol while using this medication because it can increase the risk of developing hypoglycemia.During times of stress, such as fever, infection, injury or surgery, it may be more difficult to control your blood sugar. Consult your doctor because a change in your medication or how often you test your blood sugar may be required.If traveling across time zones, ask your doctor about how to adjust your insulin schedule. Take extra insulin and supplies with you.The elderly may be more sensitive to the effects of this drug, especially hypoglycemia.Children may be more sensitive to the effects of this drug, especially hypoglycemia.Tell your doctor if you are pregnant before using this medication. If you are planning pregnancy, discuss a plan for managing your blood sugars with your doctor before you become pregnant. Your doctor may switch the type of insulin you use during pregnancy. Consult your doctor for more details.It is not known whether this drug passes into breast milk. Consult your doctor before breast-feeding.
Drug interactions
Drug interactions may change how your medications work or increase your risk for serious side effects. This document does not contain all possible drug interactions. Keep a list of all the products you use (including prescription/nonprescription drugs and herbal products) and share it with your doctor and pharmacist. Do not start, stop, or change the dosage of any medicines without your doctor's approval.A product that may interact with this drug is: rosiglitazone.Beta-blocker medications (e.g., metoprolol, propranolol, glaucoma eye drops such as timolol) may prevent the fast/pounding heartbeat you would usually feel when your blood sugar level falls too low (hypoglycemia). Other symptoms of low blood sugar such as dizziness, hunger, or sweating are unaffected by these drugs.Many drugs can affect your blood sugar levels, making it more difficult to control your blood sugar. Before you start, stop, or change any medication, talk with your doctor or pharmacist about how the medication may affect your blood sugar. Check your blood sugar levels regularly as directed by your doctor. Tell your doctor about the results and of any symptoms of high or low blood sugar. (See also Side Effects section.) Your doctor may need to adjust your anti-diabetic medication, exercise program, or diet.Check the labels on all your medicines (e.g., cough-and-cold products) because they may contain ingredients that could affect your blood sugar. Ask your pharmacist about the safe use of those products.
Side effects
Injection site reactions (e.g., pain, redness, irritation) may occur. If any of these effects persist or worsen, notify your doctor or pharmacist promptly.Remember that your doctor has prescribed this medication because he or she has judged that the benefit to you is greater than the risk of side effects. Many people using this medication do not have serious side effects.Tell your doctor immediately if this unlikely but serious side effect occurs: muscle pain.This medication can cause low blood sugar (hypoglycemia). This effect may occur if you do not consume enough calories (from food, juices, fruit, etc.) or you have used too much insulin glulisine. The symptoms include chills, cold sweat, blurred vision, dizziness, drowsiness, shaking, rapid heart rate, weakness, headache, fainting, tingling of the hands or feet, or hunger. It is a good habit to carry glucose tablets or gel to treat low blood sugar. If you are in a situation where you don't have these reliable forms of glucose, eat a quick source of sugar such as table sugar, honey, or candy, or drink a glass of orange juice or non-diet soda to quickly raise your blood sugar level. Tell your doctor immediately about the reaction. To help prevent hypoglycemia, eat meals on a regular schedule and do not skip meals. Check with your doctor or pharmacist about what you should do if you miss a meal.Too little insulin glulisine can cause symptoms of high blood sugar (hyperglycemia). Symptoms include thirst, increased urination, confusion, drowsiness, flushing, rapid breathing, or fruity breath odor. If these symptoms occur, tell your doctor immediately. Your dosage may need to be increased.A very serious allergic reaction to this drug is unlikely, but seek immediate medical attention if it occurs. Symptoms of a serious allergic reaction may include: rash, itching/swelling (especially of the face/tongue/throat), severe dizziness, fast heartbeat, sweating, trouble breathing.This is not a complete list of possible side effects. If you notice other effects not listed above, contact your doctor or pharmacist.In the US -Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.In Canada - Call your doctor for medical advice about side effects. You may report side effects to Health Canada at 1-866-234-2345.
Missed dose
It is very important to follow your insulin regimen exactly. Do not miss any doses of insulin. Discuss specific instructions with your doctor now in case you miss a dose of insulin in the future.
Overdose
If overdose is suspected, contact your local poison control center or emergency room immediately. US residents can call the US national poison hotline at 1-800-222-1222. Canadian residents should call their local poison control center directly. Symptoms of overdose may include: shakiness, rapid heartbeat, unexplained sweating, loss of consciousness.
Notes
Do not share this medication, needles, or syringes with others.It is recommended you attend a diabetes education program to understand diabetes and all the important aspects of its treatment, including meals/diet, exercise, personal hygiene, medications, and getting regular eye, foot and medical exams.Keep all medical appointments. Laboratory and/or medical tests (e.g., liver and kidney function tests, fasting blood glucose, hemoglobin A1c, complete blood counts) should be performed periodically to monitor for side effects and response to therapy. Check your blood sugar levels regularly as directed by your doctor or pharmacist.Wear or carry identification stating that you have diabetes and are using this drug. See Medical Alert section.
Medical alert
Your condition can cause complications in a medical emergency. For enrollment information call MedicAlert at 1-800-854-1166 (USA) or 1-800-668-1507 (Canada).
Storage
It is best to refrigerate the unopened vial/cartridge/pen between 36-46 degrees F (2-8 degrees C). Do not freeze. Discard the insulin if it has been frozen. Unopened insulin may also be stored at room temperature below 77 degrees F (25 degrees C), but in that case it must be discarded after 28 days.Opened vials may be stored in the refrigerator or at room temperature.Opened cartridges with the delivery device attached should not be refrigerated but should be kept at room temperature. Do not store the delivery device in the refrigerator.Opened pens should not be refrigerated but should be kept at room temperature.When stored at room temperature, opened containers should be kept below 77 degrees F (25 degrees C), away from direct heat and light. Discard all opened containers of insulin glulisine 28 days after opening.If using this drug in an insulin pump, do not store this drug in the pump for more than 48 hours. Doing so may lead to ineffective therapy and high blood sugars. Do not expose the insulin in your pump to direct sunlight or temperatures above 98.6 degrees F (37 degrees C).Keep all medicines away from children and pets.Do not flush medications down the toilet or pour them into a drain unless instructed to do so. Properly discard this product when it is expired or no longer needed. Consult your pharmacist or local waste disposal company for more details about how to safely discard your product.
Photos by medication strength
Click the "Photos" link to see sample photographs for a specific medication strength.
Common strengths 
Apidra SoloStar 100 unit/mL Sub-Q Insulin Pen
Important note
HOW TO USE THIS INFORMATION: This is a summary and does NOT have all possible information about this product. This information does not assure that this product is safe, effective, or appropriate for you. This information is not individual medical advice and does not substitute for the advice of your health care professional. Always ask your health care professional for complete information about this product and your specific health needs.

Information last revised April 2012. Copyright(c) 2012 First Databank, Inc.
Subcutaneous
Insulin Pen

Insulin Glulisine|
Adult Onset DM|Ketosis-Resistant Diabetes Mellitus|Non-Insulin-Dependent Diabetes Mellitus|Maturity Onset Diabetes|Adult Onset Diabetes|Maturity Onset Diabetes Mellitus|Ketosis-Resistant DM|Type II Diabetes Mellitus|Diabetes Mellitus Type 2|Adult Onset Diabetes Mellitus|Diabetes Beginning in Adulthood - Type 2/Adult Onset|Non-Insulin Dependent Diabetes Mellitus|Diabetes Mellitus Type II|Juvenile Diabetes|Insulin-Dependent DM|Insulin-Dependent Diabetes Mellitus|Ketosis-Prone Diabetes Mellitus|Ketosis-Prone Diabetes|Juvenile-Onset Diabetes|Juvenile-Onset Diabetes Mellitus|Juvenile Onset DM|Type I Diabetes Mellitus|Diabetes Mellitus Type 1|Ketosis-Prone DM|Insulin Dependent Diabetes Mellitus|Immune Mediated Diabetes Mellitus|
Type 2 Diabetes Mellitus|Type 1 Diabetes Mellitus|Diabetes Mellitus with Severe Insulin Resistance|
Non-Insulin-Dependent Diabetes|Type I Diabetes|Insulin-Dependent Diabetes|
AODM|NIDDM|IDDM|
Selected from NATIONAL DRUG DATA FILE (NDDF) data included with permission and copyrighted by First DataBank, Inc., 2012. This copyrighted material has been downloaded from a licensed data provider.

The above information is intended to supplement, not substitute for, the expertise and judgment of your health care professional. You should consult your health care professional before taking any drug, changing your diet, or commencing or discontinuing any course of treatment.

责任编辑:admin


相关文章
ABASAGLAR(甘精胰岛素注射用笔/注射器)
HumatroPen(somatropin [rDNA origin] for injection)
Lantus SoloStar(蘭德仕注射劑)
LANTUS SOLOSTAR(重组甘精胰岛素注射剂/笔)
谷赖胰岛素注射液(アピドラ注ソロスター,APIDRA®)
Levemir(insulin detemir,注射用地特胰岛素[rDNA 来源])
NORDITROPIN CARTRIDGES(生长激素[rDNA来源]注射剂/预填充笔)
 

最新文章

更多

· 新长效胰岛素TOUJEO注射...
· 2型糖尿病新类复方药Syn...
· 每周口服一次的降糖重磅...
· 新类复方制剂Juvisync(降...
· 糖尿病新类药Trulicity(...
· 新型降糖药Glyxambi(恩格...
· 2型糖尿病新药Eperzan(A...
· trelagliptin succinate...
· omarigliptin(每周一次...
· 武田2型糖尿病药物alogl...

推荐文章

更多

· 新长效胰岛素TOUJEO注射...
· 2型糖尿病新类复方药Syn...
· 每周口服一次的降糖重磅...
· 新类复方制剂Juvisync(降...
· 糖尿病新类药Trulicity(...
· 新型降糖药Glyxambi(恩格...
· 2型糖尿病新药Eperzan(A...
· trelagliptin succinate...
· omarigliptin(每周一次...
· 武田2型糖尿病药物alogl...

热点文章

更多

· 新长效胰岛素TOUJEO注射...